Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management, LP | 8,520,000 9.980% | 2,860,000 (+50.53%) | Filing History |
| 2025-02-12 11:39 am Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | GOLDMAN SACHS GROUP INC GS | 5,953,465 7.000% | 5,953,465 (New Position) | Filing History |
| 2025-02-05 10:03 am Purchase | 2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | MORGAN STANLEY MS | 5,362,169 6.300% | 5,362,169 (New Position) | Filing History |
| 2025-01-22 5:50 pm Purchase | 2025-01-21 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 4,277,847 5.000% | 1,443,348 (+50.92%) | Filing History |
| 2024-12-06 4:28 pm Purchase | 2024-11-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 8,787,650 10.300% | 548,570 (+6.66%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 8,239,080 9.700% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Sale | 2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | WELLINGTON MANAGEMENT GROUP LLP | 4,985,976 5.860% | -2,599,245 (-34.27%) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 8,239,080 9.700% | 1,223,532 (+17.44%) | Filing History |
| 2024-10-18 11:49 am Sale | 2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 3,770,826 4.400% | -1,245,398 (-24.83%) | Filing History |
| 2024-02-14 12:50 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management, LP | 5,660,000 6.670% | 5,660,000 (New Position) | Filing History |
| 2024-02-14 07:01 am Sale | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 2,834,499 3.300% | -685,903 (-19.48%) | Filing History |
| 2024-02-13 9:44 pm Sale | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 3,950,000 4.700% | -2,768,142 (-41.20%) | Filing History |
| 2024-02-13 5:15 pm Purchase | 2023-12-29 | 13G | Syndax Pharmaceuticals, Inc. SNDX | VANGUARD GROUP INC | 4,335,353 5.110% | 4,335,353 (New Position) | Filing History |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Syndax Pharmaceuticals, Inc. SNDX | WELLINGTON MANAGEMENT GROUP LLP | 7,585,221 8.940% | -398,221 (-4.99%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | BlackRock Inc. BLK | 7,015,548 8.300% | 2,663,516 (+61.20%) | Filing History |
| 2024-01-25 11:20 am Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 5,016,224 5.910% | 1,367,761 (+37.49%) | Filing History |
| 2023-10-31 4:26 pm Purchase | 2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 3,520,402 5.100% | 3,520,402 (New Position) | Filing History |
| 2023-10-05 12:23 pm Sale | 2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -3,708,838 (Position Closed) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Nantahala Capital Management, LLC | 975,705 1.400% | -2,074,854 (-68.02%) | Filing History |
| 2023-02-14 3:47 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 6,718,142 9.700% | 1,474,123 (+28.11%) | Filing History |